MNKD (mannkindcorp.com) יחס שווי שוק לשווי בספרים
MannKind Corporation (MNKD) is an innovator in dry powder molecular engineering that developed the unique Technosphere delivery system. By customizing therapies for orphan diseases, MannKind Corporation (MNKD) occupies a specialized niche, avoiding price wars with industry behemoths. This chart of the company's price action on the GURU.Markets platform shows a level of -15.16. The business's success relies on patent protection and physician recognition of inhaled insulin.
%3A%20%D7%A9%D7%95%D7%95%D7%99%20%D7%A9%D7%95%D7%A7%20%D7%91%D7%99%D7%97%D7%A1%20%D7%9C%D7%A0%D7%9B%D7%A1%D7%99%D7%9D%20%D7%A0%D7%A7%D7%99%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_MNKD_-_MannKind-Corporation_-_Market-Capitalization-to-Net-Assets "MNKD יחס שווי שוק לערך בספרים Afrezza (04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
פילוחי מדדים פיננסיים ומדדי שוק עבור MannKind Corp (MNKD)
The monetization of the Technosphere platform and the development of orphan drugs drive the investment attractiveness of MannKind Corporation (MNKD), which is reflected in the market value premium over net assets. The current value of -15.16 in the company's market-to-book ratio demonstrates the market's confidence in future royalties, allowing investors to assess the extent of the premium paid for intellectual capital relative to the book value.